MétaCan
Menu
← Back to cohort

Prevalence of immune-related adverse events (irAEs) and association with symptom distress score by Edmonton Symptom Assessment System (ESAS) in solid cancer patients receiving immune checkpoint inhibitor (ICI) therapy.

2025· article· en· W4410811468 on OpenAlexaboutno aff
Sudpreeda Chainitikun, Siyamol Mingmalairak, Panida Saetan, Siriwan Tangjitgamol

Bibliographic record

VenueJournal of Clinical Oncology · 2025
Typearticle
Languageen
FieldMedicine
TopicCancer survivorship and care
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineAdverse effectImmune systemDistressAssociation (psychology)Internal medicineCancerOncologyPsychiatryClinical psychologyPsychotherapistImmunology

Abstract

fetched live from OpenAlex

e23191 Background: Immune-related adverse events (irAEs) after immunotherapy are unique and unpredictable, differing from chemotherapy or targeted therapy. The impact of irAEs during treatment on symptom distress and quality of life of the patients remains unclear. We hypothesized that irAEs affect the patient-report outcomes, as assessed by the Edmonton Symptom Assessment System (ESAS). This study aimed to evaluate the association between irAEs and ESAS. Methods: We conducted a retrospective study of patients diagnosed with solid cancer who received immune checkpoint inhibitor (ICI) therapy from December 2021-August 2024 at MedPark hospital, Thailand. Patients’ health status was routinely evaluated at each visit using ESAS. Baseline clinical characteristics and irAEs were collected. The ESAS score was calculated to a total symptom distress score (TSDS) based on the sum of the first nine physical and psychosocial symptoms. TSDS was collected before ICI treatment (baseline) and after ICI treatment at three time points (4, 8, and 12 weeks post-treatment). The outcome measures were the prevalence of irAEs and post-treatment TSDS compared to baseline TSDS in both irAEs and non-irAEs groups. Results: A total of 39 patients (24 women,15 men) were analyzed.The mean age was 59.1 years (range 33-88). Lung cancer was the most common diagnosis (28.2%) followed by breast cancer (17.9%). All grades of irAEs were evidenced in 48.7%, with a median time to irAEs onset of 8.8 weeks (interquartile range: 4.9-12.6 weeks). The most common irAEs was hypothyroid (20.5%). Grade ≥3 irAEs occurred in 7.7% of patients, including two cases of pneumonitis and one case of hepatitis. Baseline TSDS was 12.63 in the irAEs group and 11.9 in the non-irAEs group. Post-treatment TSDS showed slight improvement (decreased scores) compared to baseline in both groups, with a mean difference of -0.48 (SD,10.9; p = 0.788); -0.31 in irAEs group and -0.63 in non-irAEs group. Compared to baseline, the mean differences of post-treatment TSDS in the irAEs and non-irAEs groups were 1.07 vs 1.26, -2.29 vs -3.79, and -1.57 vs 0.84 at 4, 8 and 12weeks, respectively. Conclusions: irAEs were experienced by nearly half of the patients undergoing ICI therapy. The presence of irAEs did not significant change ESAS score during ICI treatment.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.003

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.020
GPT teacher head0.377
Teacher spread0.357 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicCancer survivorship and care→French-language works237,207→